Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries.

Salvatore CrisafulliIsabel HurtadoDaniel Bejarano-QuisoboniFrancesco GiorgianniKrista F HuybrechtsZhigang LuElisabetta PatornoGabriel Sanfélix-GimenoDaniele Ugo TariGianluca Trifirò

Published in: European journal of clinical pharmacology (2019)

Antipsychotic utilization was heterogeneous among persons with schizophrenic disorder. Nevertheless, low persistence was an issue in all the countries, as less than half of the patients continued their treatment beyond 1 year.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported
smoking cessation